Expression of Constitutively Active Guanylate Cyclase in Cardiomyocytes Inhibits the Hypertrophic Effects of Isoproterenol and Aortic Constriction on Mouse Hearts
Open Access
- 1 November 2003
- journal article
- Published by Elsevier BV
- Vol. 278 (48), 47694-47699
- https://doi.org/10.1074/jbc.m309661200
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Guanosine 3′: 5′‐cyclic monophosphate‐dependent pathway alterations in ventricular cardiomyocytes of spontaneously hypertensive ratsBritish Journal of Pharmacology, 2001
- Cytoplasmic Signaling Pathways That Regulate Cardiac HypertrophyAnnual Review of Physiology, 2001
- Guanylate cyclase and the ⋅NO/cGMP signaling pathwayBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1999
- Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice.JCI Insight, 1998
- Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.JCI Insight, 1998
- A Noninvasive Computerized Tail-Cuff System for Measuring Blood Pressure in MiceHypertension, 1995
- Effects of C‐Type Natriuretic Peptide on Rat Astrocytes: Regional Differences and Characterization of ReceptorsJournal of Neurochemistry, 1994
- C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3',5'-monophosphate.Hypertension, 1992
- A membrane form of guanylate cyclase is an atrial natriuretic peptide receptorNature, 1989
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978